Get started
Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Price target

6.600.000.00%
The 5 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings in the past 3 months.

EPS

Reported
Estimate
Metrics
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Metrics
Reported
Estimate
Surprise
Disclaimer
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.

Frequently asked questions


The current price of ALDX is 1.52 USD — it has decreased by −1.94% in the past 24 hours. Watch Aldeyra Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aldeyra Therapeutics, Inc. stocks are traded under the ticker ALDX.
ALDX stock has fallen by −10.59% compared to the previous week, the month change is a −26.21% fall, over the last year Aldeyra Therapeutics, Inc. has showed a −72.51% decrease.
We've gathered analysts' opinions on Aldeyra Therapeutics, Inc. future price: according to them, ALDX price has a max estimate of 13.00 USD and a min estimate of 2.00 USD. Watch ALDX chart and read a more detailed Aldeyra Therapeutics, Inc. stock forecast: see what analysts think of Aldeyra Therapeutics, Inc. and suggest that you do with its stocks.
ALDX reached its all-time high on Sep 26, 2018 with the price of 16.70 USD, and its all-time low was 1.07 USD and was reached on Mar 17, 2026. View more price dynamics on ALDX chart.
See other stocks reaching their highest and lowest prices.
ALDX stock is 8.47% volatile and has beta coefficient of 2.88. Track Aldeyra Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Aldeyra Therapeutics, Inc. there?
Today Aldeyra Therapeutics, Inc. has the market capitalization of ‪91.69 M‬, it has decreased by −12.44% over the last week.
Yes, you can track Aldeyra Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Aldeyra Therapeutics, Inc. is going to release the next earnings report on Jul 31, 2026. Keep track of upcoming events with our Earnings Calendar.
ALDX earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.10 USD resulting in a 38.46% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about Aldeyra Therapeutics, Inc. earnings.
Aldeyra Therapeutics, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALDX net income for the last quarter is ‪−3.45 M‬ USD, while the quarter before that showed ‪−6.46 M‬ USD of net income which accounts for 0.00% change. Track more Aldeyra Therapeutics, Inc. financial stats to get the full picture.
No, ALDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 26, 2026, the company has 8 employees. See our rating of the largest employees — is Aldeyra Therapeutics, Inc. on this list?
Like other stocks, ALDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aldeyra Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aldeyra Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aldeyra Therapeutics, Inc. stock shows the sell signal. See more of Aldeyra Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.